CMPX Compass Therapeutics, Inc.
Price Chart
Executive Summary
Compass Therapeutics filed a DEFA14A (additional definitive proxy soliciting materials) on April 29, 2026. The filing content is unavailable, but the presence of dissident-proxy cross-filing amplifiers suggests a potential activist or proxy contest context. Without specific details, the impact remains uncertain.
Actionable Insight
Monitor for definitive proxy materials or subsequent filings that may reveal the nature of the proxy solicitation. The dissident-proxy amplifiers suggest heightened activist risk, but no concrete demands or financial data are available yet.
Key Facts
- Filed DEFA14A on 2026-04-29
- Market cap: $331M
- Amplifiers indicate dissident-proxy context
- Document content unavailable
Financial Impact
Not determinable from filing metadata alone
Risk Factors
- Potential activist intervention or board challenge
- Uncertainty due to lack of filing content
Market Snapshot
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001140361-26-017650 |
| Document: 0001140361-26-017650-index-headers.html | 0001140361-26-017650 |
| Document: 0001140361-26-017650-index.html | 0001140361-26-017650 |
| Document: 0001140361-26-017650.txt | 0001140361-26-017650 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
May 21, 2026
19d ago
|
Press Release
| $2.07 $2.22 | ▲ +7.25% | ▲ +5.57% | $2.06 (−0.48%) |
|
May 5, 2026
5w ago
|
8-K
| $1.95 $1.83 | ▼ −6.15% | ▼ −8.14% | $2.06 (+5.64%) |
|
Apr 29, 2026
5w ago
|
DEFA14A
| $1.67 $1.95 | ▲ +16.77% | ▲ +13.66% | $2.06 (+23.35%) |
|
Apr 27, 2026
6w ago
|
8-K
| $1.79 $1.94 | ▲ +8.38% | ▲ +7.98% | $2.06 (+15.08%) |
|
Apr 27, 2026
6w ago
|
Press Release
| $1.79 $1.94 | ▲ +8.38% | ▲ +7.98% | $2.06 (+15.08%) |
|
Apr 24, 2026
6w ago
|
Press Release
| $1.79 $1.94 | ▲ +8.38% | ▲ +7.98% | $2.06 (+15.08%) |
|
Mar 5, 2026
13w ago
|
8-K / PRESS-RELEASE
| $5.53 $5.19 | ▼ −6.15% | ▼ −3.91% | $2.06 (−62.75%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access